| |
| |
|
| Insider
Information: |
Washington Robin L |
| Relationship: |
Director |
| City: |
Beaverton |
| State: |
OR |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
94,216 |
|
|
Indirect Shares
|
129,113 |
|
|
| Direct
Value |
$18,372,284 |
|
|
|
Indirect Value
|
$10,114,071 |
|
|
| Total
Shares |
223,329 |
|
|
| Total
Value |
$28,486,355 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tektronix Inc |
TEK |
Resigned as Director 1... |
2007-11-21 |
0 |
2005-09-26 |
0 |
Premium* |
|
|
Gilead Sciences Inc |
GILD |
EVP, CFO |
2019-02-25 |
21,620 |
2019-02-25 |
117,323 |
Premium* |
|
|
Mips Technologies Inc |
MIPS |
Director |
2013-02-07 |
0 |
2010-11-11 |
0 |
Premium* |
|
|
Salesforce.com Inc |
CRM |
Director |
2024-05-22 |
40,815 |
2013-11-26 |
0 |
Premium* |
|
|
Honeywell International Inc |
HON |
Director |
2024-04-15 |
340 |
2024-04-15 |
11,790 |
Premium* |
|
|
Alphabet Inc |
GOOG |
Director |
2023-07-05 |
31,441 |
2019-05-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
EVP, CFO |
• – – |
2015-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
97,892 |
147,972 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, CFO |
• – – |
2014-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
77,000 |
126,832 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, CFO |
• – – |
2015-02-17 |
4 |
D |
$103.84 |
$6,502,045 |
D/D |
(62,616) |
85,356 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, CFO |
• – – |
2015-02-26 |
4 |
A |
$0.00 |
$0 |
I/I |
57,632 |
101,471 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, CFO |
• – – |
2015-02-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
57,632 |
27,724 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, CFO |
• – – |
2012-09-17 |
4 |
OE |
$47.20 |
$2,999,010 |
D/D |
57,250 |
17,413 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, CFO |
• – – |
2012-09-17 |
4 |
S |
$64.83 |
$3,711,346 |
D/D |
(57,250) |
11,413 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, CFO |
• • – |
2016-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
48,320 |
76,292 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, CFO |
• – – |
2013-07-01 |
4 |
AS |
$51.97 |
$2,371,662 |
D/D |
(45,600) |
27,130 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, CFO |
• – – |
2013-07-01 |
4 |
OE |
$19.09 |
$1,071,190 |
D/D |
45,600 |
72,730 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, CFO |
• – – |
2013-03-05 |
4 |
AS |
$44.41 |
$1,998,450 |
D/D |
(45,000) |
23,794 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, CFO |
• – – |
2013-03-05 |
4 |
OE |
$24.30 |
$1,093,275 |
D/D |
45,000 |
68,794 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, CFO |
• – – |
2013-03-27 |
4 |
OE |
$27.07 |
$1,218,150 |
D/D |
45,000 |
73,098 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, CFO |
• – – |
2013-03-27 |
4 |
AS |
$47.07 |
$2,118,150 |
D/D |
(45,000) |
28,098 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, CFO |
• – – |
2014-03-06 |
4 |
D |
$79.92 |
$3,211,186 |
D/D |
(40,180) |
86,652 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, CFO |
• – – |
2014-03-17 |
4 |
A |
$0.00 |
$0 |
I/I |
36,820 |
63,600 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, CFO |
• – – |
2014-03-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
36,820 |
49,832 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, CFO |
• – – |
2013-09-30 |
4 |
AS |
$62.99 |
$2,252,916 |
D/D |
(35,600) |
27,130 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, CFO |
• – – |
2013-09-30 |
4 |
OE |
$19.09 |
$800,490 |
D/D |
35,600 |
62,730 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, CFO |
• – – |
2014-01-02 |
4 |
AS |
$75.03 |
$2,671,214 |
D/D |
(35,600) |
0 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, CFO |
• – – |
2014-01-02 |
4 |
OE |
$19.09 |
$800,490 |
D/D |
35,600 |
35,600 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, CFO |
• • – |
2017-09-07 |
4 |
OE |
$24.30 |
$819,956 |
D/D |
33,750 |
43,352 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, CFO |
• • – |
2017-09-07 |
4 |
AS |
$85.00 |
$2,868,750 |
D/D |
(33,750) |
9,602 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, CFO |
• – – |
2014-08-14 |
4 |
OE |
$40.56 |
$1,361,031 |
D/D |
33,556 |
83,388 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, CFO |
• – – |
2014-08-14 |
4 |
AS |
$95.56 |
$3,206,611 |
D/D |
(33,556) |
49,832 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
